Modifying immune responses to adeno-associated virus vectors by capsid engineering
Authors:
Open Access
- 22 August 2023
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 30, 576-592
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation
- Federal Ministry of Education and Research Bonn Office
- Sächsisches Staatsministerium für Wissenschaft und Kunst
This publication has 60 references indexed in Scilit:
- CpG-depleted adeno-associated virus vectors evade immune detectionJournal of Clinical Investigation, 2013
- MyD88 Signaling in B Cells Regulates the Production of Th1-dependent Antibodies to AAVMolecular Therapy, 2012
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BNew England Journal of Medicine, 2011
- Adeno-Associated Virus Antibody Profiles in Newborns, Children, and AdolescentsClinical and Vaccine Immunology, 2011
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- Adeno-associated Virus Vectors Serotype 2 Induce Prolonged Proliferation of Capsid-Specific CD8+ T Cells in MiceMolecular Therapy, 2011
- Rosetta32011
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signallingNature, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999